106 related articles for article (PubMed ID: 21549583)
41. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.
Oosterveer MH; Grefhorst A; Groen AK; Kuipers F
Prog Lipid Res; 2010 Oct; 49(4):343-52. PubMed ID: 20363253
[TBL] [Abstract][Full Text] [Related]
42. PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism.
Wende AR; Huss JM; Schaeffer PJ; Giguère V; Kelly DP
Mol Cell Biol; 2005 Dec; 25(24):10684-94. PubMed ID: 16314495
[TBL] [Abstract][Full Text] [Related]
43. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
Chen Y; Li Y; Wang Y; Wen Y; Sun C
Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
[TBL] [Abstract][Full Text] [Related]
44. Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists.
Fuster G; Busquets S; Ametller E; Olivan M; Almendro V; de Oliveira CC; Figueras M; López-Soriano FJ; Argilés JM
Cancer Res; 2007 Jul; 67(13):6512-9. PubMed ID: 17616713
[TBL] [Abstract][Full Text] [Related]
45. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia.
Beaven SW; Tontonoz P
Annu Rev Med; 2006; 57():313-29. PubMed ID: 16409152
[TBL] [Abstract][Full Text] [Related]
46. Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle.
Bouzakri K; Austin R; Rune A; Lassman ME; Garcia-Roves PM; Berger JP; Krook A; Chibalin AV; Zhang BB; Zierath JR
Diabetes; 2008 Jun; 57(6):1508-16. PubMed ID: 18314420
[TBL] [Abstract][Full Text] [Related]
47. The nuclear receptor LXR is a glucose sensor.
Mitro N; Mak PA; Vargas L; Godio C; Hampton E; Molteni V; Kreusch A; Saez E
Nature; 2007 Jan; 445(7124):219-23. PubMed ID: 17187055
[TBL] [Abstract][Full Text] [Related]
48. Putative PPAR target genes express highly in skeletal muscle of insulin-resistant MetS model SHR/NDmc-cp rats.
Hariya N; Miyake K; Kubota T; Goda T; Mochizuki K
J Nutr Sci Vitaminol (Tokyo); 2015; 61(1):28-36. PubMed ID: 25994137
[TBL] [Abstract][Full Text] [Related]
49. Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha.
Tobin KA; Steineger HH; Alberti S; Spydevold O; Auwerx J; Gustafsson JA; Nebb HI
Mol Endocrinol; 2000 May; 14(5):741-52. PubMed ID: 10809236
[TBL] [Abstract][Full Text] [Related]
50. Nuclear receptor signaling and cardiac energetics.
Huss JM; Kelly DP
Circ Res; 2004 Sep; 95(6):568-78. PubMed ID: 15375023
[TBL] [Abstract][Full Text] [Related]
51. Activation of type 2 cannabinoid receptors (CB2R) promotes fatty acid oxidation through the SIRT1/PGC-1α pathway.
Zheng X; Sun T; Wang X
Biochem Biophys Res Commun; 2013 Jul; 436(3):377-81. PubMed ID: 23747418
[TBL] [Abstract][Full Text] [Related]
52. Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-gamma dependent pathway.
Sugimoto K; Kazdová L; Qi NR; Hyakukoku M; Kren V; Simáková M; Zídek V; Kurtz TW; Pravenec M
J Hypertens; 2008 Jun; 26(6):1209-15. PubMed ID: 18475159
[TBL] [Abstract][Full Text] [Related]
53. Cellular mechanisms regulating fuel metabolism in mammals: role of adipose tissue and lipids during prolonged food deprivation.
Viscarra JA; Ortiz RM
Metabolism; 2013 Jul; 62(7):889-97. PubMed ID: 23357530
[TBL] [Abstract][Full Text] [Related]
54. Metabolic flexibility is conserved in diabetic myotubes.
Gaster M
J Lipid Res; 2007 Jan; 48(1):207-17. PubMed ID: 17062897
[TBL] [Abstract][Full Text] [Related]
55. Adopted orphans as regulators of inflammation, immunity and skeletal homeostasis.
Ipseiz N; Scholtysek C; Culemann S; Krönke G
Swiss Med Wkly; 2014; 144():w14055. PubMed ID: 25474159
[TBL] [Abstract][Full Text] [Related]
56. The evolving understanding of the contribution of lipid metabolism to diabetic kidney disease.
Stadler K; Goldberg IJ; Susztak K
Curr Diab Rep; 2015 Jul; 15(7):40. PubMed ID: 25957525
[TBL] [Abstract][Full Text] [Related]
57. Time-dependent reduction in oxidative capacity among cultured myotubes from spinal cord injured individuals.
Stevanovic S; Dalmao-Fernandez A; Mohamed D; Nyman TA; Kostovski E; Iversen PO; Savikj M; Nikolic N; Rustan AC; Thoresen GH; Kase ET
Acta Physiol (Oxf); 2024 Jul; 240(7):e14156. PubMed ID: 38711362
[TBL] [Abstract][Full Text] [Related]
58. Increased Glycolysis and Higher Lactate Production in Hyperglycemic Myotubes.
Lund J; Ouwens DM; Wettergreen M; Bakke SS; Thoresen GH; Aas V
Cells; 2019 Sep; 8(9):. PubMed ID: 31540443
[TBL] [Abstract][Full Text] [Related]
59. Pancreatic cancer cells show lower oleic acid oxidation and their conditioned medium inhibits oleic acid oxidation in human myotubes.
Krapf SA; Lund J; Lundkvist M; Dale MG; Nyman TA; Thoresen GH; Kase ET
Pancreatology; 2020 Jun; 20(4):676-682. PubMed ID: 32360002
[TBL] [Abstract][Full Text] [Related]
60. Substrate oxidation in primary human skeletal muscle cells is influenced by donor age.
Aas V; Thoresen GH; Rustan AC; Lund J
Cell Tissue Res; 2020 Dec; 382(3):599-608. PubMed ID: 32897419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
